- Home
- MIRA vs PRT Comparison
MIRA vs PRT Comparison
Compare MIRA & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRA | PRT |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 27.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRA | PRT |
|---|---|---|
| Price | $0.83 | $2.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 23.3K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $1.82 |
| 52 Week High | $2.45 | $4.01 |
Technical Indicators
Market Signals| Indicator | MIRA | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 35.57 |
| Support Level | $0.72 | $2.02 |
| Resistance Level | $0.82 | $2.32 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 20.47 | 14.29 |
Price Performance
Historical ComparisonAbout MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.